Picture this: a hurricane approaches, and the clock is ticking. In the chaos, the last thing anyone wants is to scramble for essential medications. Yet, as we witness the increasing frequency of natural disasters, the question looms large: are our drug supply chains robust enough to withstand such shocks?
The FDA has laid out critical guidance for drugs that play a pivotal role in emergency preparedness and response. This includes a focus on emergency drug supplies, FDA-approved treatments, and the necessary safety measures to protect public health. As regulatory bodies tighten their grip on quality and availability, the pharmaceutical industry must rise to the occasion. The stakes are high, and the implications of shortages or delays can be dire. Are we truly ready to respond when disaster strikes?
Source: www.fda.gov
